Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-67
SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France).

Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18-67 years

given consent for genetic analysis,

written consent for participating in the study

Disqualifiers

judicial protection or guardianship

Trial population

Adult men and women ramdomly selected from the voter registration lists in La Réunion island

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Blood, DNA, feces, urine, hair and skin microbiota collection

    Diagnostic test

    See above

Treatment groups

2,000 Participants
are divided into 1 treatment group
Group A: general population1 intervention

Trial outcomes

Primary outcomes

1

Prevalence of cardiometabolic diseases

Prevalence rates for diabetes, hypertension, obesity, dyslipidemia, smoking and subclinical atherosclerosis markers

Time frame
cross sectional (at inclusion)
2

Prevalence of infectious diseases

Seroprevalence rates for chikungunya, dengue, zika, covid19

Time frame
cross sectional (at inclusion)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.